Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Epoetin alfa
may stimulate red blood cell production to treat anemia in patients who have received
chemotherapy and/or radiation therapy for cervical cancer. Randomized phase III trial to
study the effectiveness of epoetin alfa in treating anemia in patients who have cervical
cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Gynecologic Oncology Group
Collaborators:
Canadian Cancer Trials Group National Cancer Institute (NCI) NCIC Clinical Trials Group